+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Company Analysis: Lundbeck

  • Company Profile

  • 39 Pages
  • January 2021
  • Citeline
  • H. Lundbeck A/S
  • ID: 5357325
The publisher explores Lundbeck’s prescription pharmaceutical performance and outlook over 2019-29.


  • Overview - Lundbeck’s prescription pharmaceutical sales are set to grow over the forecast period.
  • Key themes - [1] Key CNS products are expected to drive continued growth [2] Generic market entries will erode sales of five drugs [3] Acquisition of Alder BioPharmaceuticals adds Vyepti to Lundbeck’s product portfolio.

Model updates (4 November 2020)

  • Cipralex forecast adjusted higher in Rest of World
  • Onfi forecast adjusted higher due to better-than-expected performance given generic competition
  • Trintellix forecast adjusted lower in Europe.

Model updates (13 August 2020)

  • Rexulti forecast adjusted higher due to continued strong uptake in the US across schizophrenia and major depressive disorder.
  • Rexulti forecast adjusted lower in 5EU and Rest of World due to current trends as well as the discontinuation for bipolar disorder.

Model updates (12 May 2020)

  • Eptinezumab name changed to Vyepti.

Model updates (6 February 2020)

  • Eptinezumab added to forecast after acquisition of Alder BioPharmaceuticals for $1.95bn.

Table of Contents

Company Background
  • Company Overview
  • Key Metrics
  • SWOT Analysis
  • Key Drug & Company Information
  • Company Comparison

Recent Earnings Review
  • Earnings Overview
  • Notable Quotes & Important Topics
  • Pharma Insights Analysis

Company Forecast
  • Prescription Pharmaceuticals Sales Outlook
  • Branded Drug Outlook
  • Launch Profile Outlook
  • Therapy Area Outlook
  • Regional Sales Outlook
  • Lifecycle Analysis

Company Profile
  • Marketed & Pipeline Drugs
  • Recent Events & Analyst Opinions
  • Upcoming Catalysts
  • Recent Insights

Clinical Trial Overview
  • Clinical Trial Snapshot
  • Clinical Trials by Country
  • Clinical Trials by Status and Phase
  • Clinical Trials by Drug